Home World News Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised... World News Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX By Ogkologos - March 11, 2025 909 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Sleep Issue Called Hypersomnolence Can Increase The Risk Of Diabetes And... May 14, 2020 Experimental mRNA Vaccine Hints at Potential Against Glioblastoma June 11, 2024 2021 ASCO Annual Meeting Research Round Up: New Research in Gynecologic... August 16, 2021 Breast Cancer Patient Is Accused of Having “Body Image Issues” After... March 5, 2021 Load more HOT NEWS Suggesting a Deadline in the Invitation Letter to FIT Colorectal Cancer... Julia Louis-Dreyfus Talks About The Side Effects of Chemotherapy Double Mastectomies Do Not Lower Risk Of Death For Breast Cancer... ctDNA Analysis is Feasible for Detection of Minimal Residual Disease After...
